Summary
Implantable cardioverter defibrillators (ICDs) with the integrated Home Monitoring feature use dedicated mobile phone and internet links to provide the physicians and technicians in the ICD clinic with the essential device- and arrhythmia-related data stored in the ICD diagnostic memory. Various counters, graphs and intracardiac electrograms are automatically transmitted via Home Monitoring each day to allow prompt, remote presentation of arrhythmias or detection of technical problems. One of the most inconvenient side-effects of the ICD therapy is inappropriate intervention of the device. Home Monitoring data can help the physician to identify and subsequently reduce the incidence of inappropriate ICD therapy.
Similar content being viewed by others
References
Bansch D, Steffgen F, Gronefeld G, Wolpert C, Bocker D, Mletzko RU, Schols W, Seidl K, Piel M, Ouyang F, Hohnloser SH, Kuck KH (2004) The 1+1 trial: a prospective trial of a dual-versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation 110:1022–1029
Dorian P, Philippon F, Thibault B, Kimber S, Sterns L, Greene M, Newman D, Gelaznikas R, Barr A; ASTRID Investigators (2004) Randomized controlled study of detection enhancements vs rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 1:540–547
Gradaus R, Block M, Brachmann J. Breithardt G, Huber HG, Jung W, Kranig W, Mletzko RU, Schoels W, Seidl K, Senges J, Seibels J, Steinbeck G, Stellbrink C, Andresen D; German EURID Registry (2003) Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol 26:1511–1518
Grimm W, Flores BF, Marchlinski FE (1992) Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 15:1667–1673
Higgins SL (1999) Impact of the Multicenter Automatic Defibrillator Implantation Trial on implantable cardioverter defibrillator indication trends. Am J Cardiol 83:79D–82D
Hurwitz JL, Hook BG, Flores BT, Marchlinski FE (1993) Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 21:895–900
Hutten H, Kastner P, Schreier G (1997) [Cardiac telemonitoring by joining near telemetry and internet transmission] Biomed Tech (Berl) 42 (Suppl):67–69
Koos R, Sinha AM, Stellbrink C (2005) Home Monitoring in an ICD patient with incessant ventricular tachycardia. Z Kardiol 94:461–464
Medtronic Website: http://www.medtronic.com/physician/carelink/index.html
Neuser H, Schumacher B, Kottkamp H, Schmidinger H, Schuchert A, Brugada P (2004) Individualization of follow-up in implantable cardioverter-defibrillator patients with the help of automatic remote implantable cardioverter-defibrillator monitoring. (abstract) Eur Heart J 25 (Suppl Aug–Sept):166
Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, Vlahakes GJ, Garan H, Ruskin JN (1995) Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 91:2204–2213
Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA (2005) Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 149:664–669
Schmitt C, Montero M, Melichercik J (1994) Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 17:295–302
Scholten MF, Thornton AS, Theuns DA, Res J, Jordaens LJ (2004) Twiddler’s syndrome detected by Home Monitoring device. Pacing Clin Electrophysiol. 27:1151–1152
Sweeney MO, Wathen MS,Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ (2005) Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (Pain-FREE Rx II) trial. Circulation 111:2898–2905
Theuns DA, Klootwijk AP, Simoons ML, Jordaens JL (2005) Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. Am J Cardiol 95:271–274
Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ (2004) Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 44:2362–2367
Theuns DA, Res JC, Jordaens LJ (2003) Home monitoring in ICD therapy: future perspectives. Europace 5:139–142
Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg JM, DeSouza CM (2001) Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation 103:381–386
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Res, J.C.J., Theuns, D.A.M.J. & Jordaens, L. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies. Clin Res Cardiol 95 (Suppl 3), iii17–iii21 (2006). https://doi.org/10.1007/s00392-006-1304-8
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-1304-8